Growth Metrics

Oruka Therapeutics (ORKA) Share-based Compensation Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. Growth (1y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 206.26%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -69.95%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 0.18%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 0.66%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 23.70%
10 Oruka Therapeutics 3.04 Bn 2.65 Bn - 42.70%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 42.70%
Dec 31, 2025 -20.10%
Sep 30, 2025 12.93%
Jun 30, 2025 643.34%
Mar 31, 2025 4,783.00%
Dec 31, 2024 3,552.48%
Sep 30, 2024 5,744.81%
Jun 30, 2024 265.24%
Mar 31, 2024 -50.98%
Dec 31, 2023 17.50%
Sep 30, 2023 58.76%
Jun 30, 2023 8.72%
Mar 31, 2023 22.16%
Dec 31, 2022 0.84%
Sep 30, 2022 -6.73%
Jun 30, 2022 29.32%
Mar 31, 2022 18.44%
Dec 31, 2021 561.11%
Sep 30, 2021 1,980.00%
Jun 30, 2021 3,225.00%
Mar 31, 2021 781.25%
Dec 31, 2020 -33.33%
Sep 30, 2020 -82.76%
Jun 30, 2020 -91.11%
Mar 31, 2020 -68.00%
Dec 31, 2019 -53.45%
Sep 30, 2019 -50.00%
Jun 30, 2019 -25.00%
Mar 31, 2019 -48.45%
Dec 31, 2018 -51.26%
Sep 30, 2018 -51.26%
Jun 30, 2018 -49.58%
Mar 31, 2018 -3.96%
Dec 31, 2017 510.34%
Sep 30, 2017 -55.43%
Jun 30, 2017 -34.97%
Mar 31, 2017 -34.84%
Dec 31, 2016 -120.00%
Sep 30, 2016 79.19%
Jun 30, 2016 4.57%
Mar 31, 2016 19.23%
Dec 31, 2015 -7.05%
Sep 30, 2015 -7.45%
Jun 30, 2015 1.74%
Mar 31, 2015 -17.72%
Dec 31, 2014 -1.27%
Sep 30, 2014 228.57%
Jun 30, 2014 405.88%
Mar 31, 2014 276.19%
Dec 31, 2013 150.79%
Sep 30, 2013 -33.78%
Jun 30, 2013 -56.41%
Mar 31, 2013 -53.85%
Dec 31, 2012 -17.11%
Sep 30, 2012 -6.33%
Jun 30, 2012 4.00%
Mar 31, 2012 16.67%
Dec 31, 2011 -37.19%
Sep 30, 2011 -30.09%